Morphological pattern and lesion characteristics
The pathology derives its name from the specific topography of structural changes in the renal tissue:
- Focality: not all renal glomeruli are involved in the pathological process, but only separate groups of them.
- Segmentarity: within the affected glomerular apparatus, scarring involves not the entire capillary tuft, but only a separate part (segment) of it.
In the early stages of the disease, light microscopy reveals exclusively minimal structural abnormalities classified as podocytopathy. As the disease progresses, pronounced zones of sclerosis and hyalinosis begin to form in the tissue.
Due to the pronounced morphological similarity in the early stages, the scientific community hypothesizes that minimal change disease (MCD) and FSGS may represent different severity phases or variants of a single pathological process.
Pathogenesis of the primary variant
The development of primary FSGS is based on two main triggering mechanisms. The first factor is various genetic defects. The second is the systemic effect of specific circulating permeability factors. Such factors include, in particular, cardiotrophin-like cytokine-1 (belonging to the interleukin-6 family) and soluble urokinase-type plasminogen activator receptor.
Under the damaging influence of these triggers, a complex cellular mechanism is initiated:
- Pathological transdifferentiation of podocytes occurs.
- The cells lose their original functions and acquire macrophage-like properties.
- The altered podocytes initiate local fibrogenesis, ultimately leading to irreversible sclerosis of the renal glomerulus.
Clinical and laboratory profile
The clinical presentation of focal segmental glomerulosclerosis is characterized by marked protein loss. Proteinuria can manifest either as full-blown nephrotic syndrome or as persistent, treatment-refractory subnephrotic proteinuria.
An important distinguishing feature of FSGS from isolated nephrotic syndrome is the presence of concomitant symptoms. The classic clinical picture is very often complemented by manifestations of microhematuria and persistent arterial hypertension.
Therapeutic principles and prognosis
The treatment of idiopathic FSGS is based on the use of glucocorticoids (the treatment regimen is similar to MCD treatment protocols). When intensification of the therapeutic process is necessary and to increase its efficacy, physicians resort to pulse therapy, which involves the intravenous administration of high doses of methylprednisolone.
Prognosis and outcomes:
- FSGS is a leading glomerulopathy that inexorably leads to end-stage renal disease (ESRD). At this stage, the patient urgently requires transition to maintenance dialysis or other renal replacement therapy.
- Overall, the prognosis is considered unfavorable. A particularly severe course is observed in pediatric patients with massive protein loss (when daily proteinuria exceeds 10 grams).
- In transplantology, the disease is known for a high risk of recurrence: the pathology returns in the transplanted kidney in 30–50% of cases.
The term is self-explanatory: "Focal" — foci are affected (not all glomeruli); "Segmental" — only a part (segment) within a single glomerulus is affected.
Class and exam questions
At what age is FSGS most frequently diagnosed in children?
If the pathology manifests in childhood, in the vast majority of cases this occurs in school-aged children, predominantly between 6 and 15 years old.
How does FSGS clinically differ from isolated nephrotic syndrome?
In focal segmental glomerulosclerosis, the presentation of nephrotic syndrome is often accompanied by additional symptoms, such as microhematuria and arterial hypertension.
What is the main predictor of an extremely unfavorable outcome in a child?
The prognosis significantly worsens in the presence of massive proteinuria, when urinary protein loss exceeds 10 g/day.
What else to study on this topic
- Genetic defects underlying primary FSGS
- The role of soluble urokinase-type plasminogen activator receptor and cytokine-1 in pathogenesis
- Podocyte transdifferentiation: molecular mechanisms
- Methylprednisolone pulse therapy protocols in pediatrics
- Differential diagnosis of FSGS and minimal change disease
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Focal segmental glomerulosclerosis" and 3,738 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics in "Chapter 8. Kidney and Urinary Tract Diseases"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.